Back to search

Article

Repurposing Drugs for Synergistic Combination Therapies to Counteract Monkeypox Virus Tecovirimat Resistance

2024-12-23

Abstract excerpt

The ongoing monkeypox (mpox) disease outbreak has spread to multiple countries in Central Africa and evidence indicates it is driven by a more virulent clade I monkeypox virus (MPXV) strain than the clade II strain associated with the 2022 global mpox outbreak, which led the WHO to declare this mpox outbreak a public health emergency of inter-national concern. The FDA-approved small molecule antiviral tecovirimat...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
dd5a07d6-b51e-5efe-8260-2e0b956c8cb8
DOI
10.20944/preprints202412.1947.v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Repurposing Drugs for Synergistic Combination Therapies to Counteract Monkeypox Virus Tecovirimat ResistanceDOI 10.20944/preprints202412.1947.v1
Select a neighboring publication to make it the new centre.